South African Medical Journal (Feb 2018)
Is there transparency in the pricing of medicines in the South African private sector
Abstract
Recent investigations by the Competition Commission of South Africa (SA) of suspected excessive pricing of cancer medicines in SA by three global pharmaceutical companies have once again drawn attention to increasing medicine pricing transparency and warrant further public debate.